Tandem Diabetes Care (TNDM) Non Operating Income (2024 - 2026)
Tandem Diabetes Care (TNDM) posted Non Operating Income of $3.6 million for Q1 2026, up 20.23% on a QoQ basis from $3.0 million in Q4 2025, and down 13.52% year-over-year from $4.2 million in Q1 2025.
Tandem Diabetes Care (TNDM) Non Operating Income (2024 - 2026) Analysis & Trends
Tandem Diabetes Care's Non Operating Income history runs 3 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- Quarterly Non Operating Income fell 13.52% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 49.51% YoY) and the FY2025 annual result came in at $9.1 million, down 49.5% from the prior year.
- Non Operating Income was $3.6 million for Q1 2026 at Tandem Diabetes Care, up from $3.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $5.3 million in Q3 2024 and bottomed at -$632000.0 in Q2 2025.
- A 3-year average of $3.2 million and a median of $3.3 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2025 — Non Operating Income slumped 122.38% — and 2026, when it fell 13.52%.
- Tandem Diabetes Care's Non Operating Income stood at $4.5 million in 2024, then plunged by 33.14% to $3.0 million in 2025, then grew by 20.23% to $3.6 million in 2026.
- Business Quant data shows TNDM's Non Operating Income at $3.6 million in Q1 2026, $3.0 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | 3.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.63 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Jun 30, 2025 | -632,000.00 |
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 5.34 Mn |
| Jun 30, 2024 | 2.82 Mn |